Concepedia

Author

Fortunato Morabito

Azienda Ospedaliera di CosenzaORCID

Also Known As

F Morabito, F. Morabito, Fortunato MORABITO, Fortunato Morabito, Francesco Mendicino, Gabriele Buda, M.B. Fortunato, Morabito Fortunato, Morabito, F, Morabito, Fortunato

672

Publications

11.8K

Citations

56

H-Index

105

Concepts

All Affiliations

Azienda Ospedaliera di CosenzaIstituti di Ricovero e Cura a Carattere ScientificoFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoUniversity of MilanAzienda ospedaliera "Bianchi-Melacrino-Morelli"
FM

About

Fortunato Morabito is an author at Azienda Ospedaliera di Cosenza specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

74

3K

2

Health Sciences

20

30

1.6K

3

Natural Sciences

3

3

104

4

Public Health

1

1

14

5

Allergy

1

1

24

Fortunato Morabito

×

191

Publications

9.3K

Citations

53

H-Index

YearCitations

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli,

Journal of Clinical Oncology

2010

424

European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

Evangelos Terpos, Martina Kleber, Monika Engelhardt,

Haematologica

2015

391

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Antonio Palumbo, Michèle Cavo, Elena Zamagni,

Journal of Clinical Oncology

2011

320

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli,

Blood

2015

212

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

Antonio Palumbo, Sara Bringhen, Alessandra Larocca,

Journal of Clinical Oncology

2014

210

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

Monika Engelhardt, Evangelos Terpos, Martina Kleber,

Haematologica

2014

209

CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

Silvia Deaglio, Andrea Capobianco, L Bergui,

Blood

2003

184

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo,

Blood

2006

181

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

Katrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama,

Clinical Cancer Research

2016

171

CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients With Acute Promyelocytic Leukemia Treated With Simultaneous All-Trans-Retinoic Acid and Chemotherapy

Felicetto Ferrara, Fortunato Morabito, Bruno Martino,

Journal of Clinical Oncology

2000

168

Page 1